| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Alignment Healthcare, Inc.'s insiders have reduced their positions by a net 1,066,967 shares worth roughly $13.7M. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.48M | $99.59M | - | |
| 10% | 13.48M | $99.59M | - | |
| VP | 1.08M | $7.98M | - | |
| Pres | 794.6K | $5.87M | - | |
| CEO | 590.8K | $4.37M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2024 | Joseph S Konowiecki50 | Director | Sell | 16,413 | $11.77 | $193,181.01 | -1.4% | -4.0% | +42.8% | |
| Sep 16, 2024 | Dawn Christine Maroney57 | President, Markets | Sell10b5-1 | 30,000 | $11.70 | $351,027.00 | -1.7% | -2.6% | +43.7% | |
| Sep 16, 2024 | John E Kao68 | Chief Executive Officer | Sell10b5-1 | 90,000 | $11.70 | $1,052,874.00 | -3.3% | -2.6% | +43.7% | |
| Sep 13, 2024 | Joseph S Konowiecki50 | Director | Sell10b5-1 | 50,000 | $11.50 | $575,105.00 | -4.1% | -6.5% | +34.9% | |
| Sep 13, 2024 | Robert Thomas Freeman58 | Chief Financial Officer | Sell10b5-1 | 143,561 | $11.05 | $1,585,755.26 | -35.2% | -6.5% | +34.9% | |
| Sep 12, 2024 | Hakan Kardes | Chief Experience Officer | Sell10b5-1 | 25,000 | $11.48 | $287,052.50 | -6.2% | +1.3% | +38.5% | |
| Sep 11, 2024 | Christopher J Joyce47 | Chief Legal and Admin. Officer | Sell10b5-1 | 34,626 | $9.61 | $332,925.06 | -8.7% | +8.0% | +52.1% | |
| Sep 5, 2024 | Christopher J Joyce47 | Chief Legal and Admin. Officer | Sell10b5-1 | 5,841 | $10.00 | $58,421.81 | -1.4% | +27.2% | +61.2% | |
| Sep 5, 2024 | Robert Thomas Freeman58 | Chief Financial Officer | Sell10b5-1 | 6,439 | $10.00 | $64,413.09 | -1.6% | +27.2% | +61.2% | |
| Aug 23, 2024 | Dawn Christine Maroney57 | President, Markets | Sell10b5-1 | 10,000 | $9.03 | $90,289.45 | -0.6% | +30.5% | +70.9% |